methamphetamine

Documents about methamphetamine

• Non-Abstinence Outcomes in Methamphetamine Use Disorder#994019ClinicalTrials.gov
• An Study of Aripiprazole in the Treatment of Methamphetamine Dependence#841467ClinicalTrials.gov
• Modafinil for Methamphetamine Dependence#850805ClinicalTrials.gov
• Varenicline vs Placebo for the Treatment of Methamphetamine Dependence#857432ClinicalTrials.gov
• Theta Burst TMS for Treatment of Methamphetamine Use Disorder#827607ClinicalTrials.gov
• Methamphetamine Cue-reactivity#864799ClinicalTrials.gov
• Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder#846973ClinicalTrials.gov
• Pilot TMS for Methamphetamine Use Disorder#883222ClinicalTrials.gov
• Reliability, Validity, and Acceptability of a Novel Visual Scale for Estimating Daily Methamphetamine Use Among People Who Use Methamphetamine#855014ClinicalTrials.gov
• Safety Assessment of Atomoxetine With MA IV Administration#835253ClinicalTrials.gov
• Glutide for Ending Methamphetamine#831308ClinicalTrials.gov
• Safety Interaction Trial Ibudilast and Methamphetamine#911563ClinicalTrials.gov
• A Telephone-delievered Intervention to Reduce Methamphetamine Use#915665ClinicalTrials.gov
• Study of Medical Treatment for Methamphetamine Addiction#829196ClinicalTrials.gov
• rTMS for Craving in Methamphetamine Use Disorder#890711ClinicalTrials.gov
• A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence#899359ClinicalTrials.gov
• 6 U.S.C. § 220 — Methamphetamine and methamphetamine precursor chemicals#559721US Code (LII)
• Creatine for Depressed Male and Female Methamphetamine Users#883265ClinicalTrials.gov
• Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH#899952ClinicalTrials.gov
• Cardiovascular Effects of Prenatal Methamphetamine Exposure#633802ClinicalTrials.gov
• Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder#849853ClinicalTrials.gov
• Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder#869800ClinicalTrials.gov
• Development of a Methamphetamine Early Intervention#884269ClinicalTrials.gov
• Delivering Contingency Management in Outpatient Addiction Treatment#902148ClinicalTrials.gov
• DOX as a Potential Treatment for Methamphetamine Dependence#810942ClinicalTrials.gov
• Methamphetamine Effects on the Striatal Neuroimmune System#173926BYU ScholarsArchive
• Friendship Bench for Women Who Use Methamphetamine in Vietnam#825193ClinicalTrials.gov
• PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)#849214ClinicalTrials.gov
• Clandestine Methamphetamine Drug Manufacturing and Substance Use Disorders in Sri Lanka: A Case study on detection of Clandestine Methamphetamine Laboratory#237865Zenodo (CERN)
• Acceptability of Pharmacologic Treatment for Methamphetamine Dependence Among MSM#860230ClinicalTrials.gov
• Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine Users#915160ClinicalTrials.gov
• Secrets of methamphetamine manufacture#18026Open Library
• Practice Considerations For The Anesthesia Practitioner For Methamphetamine Substance Use Disorder Patients#167479EliScholar
• A Dose Ranging Study of Modafinil for Methamphetamine Dependence#881500ClinicalTrials.gov
• Tirzepatide for Obesity and Meth Use Disorder#969127ClinicalTrials.gov
• Social, Economic, and health risks among people who use Methamphetamine: Comparing three patterns of opioid Co-Use#5327Europe PMC
• Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users#979130ClinicalTrials.gov
• 21 U.S.C. § 865 — Smuggling methamphetamine or methamphetamine precursor chemicals into the United States while using facilitated entry programs#577080US Code (LII)
• Blocking IL-17A inhibits methamphetamine-induced hyperlocomotion and conditioned place preference and prevents methamphetamine abstinence-induced depression-like behaviors in mice.#301583NCBI PubMed Central
• Floatation-REST in Methamphetamine Use Disorder: A Pilot Study#826353ClinicalTrials.gov
• Crystal Clear: Purity of consumer-level methamphetamine samples and methamphetamine-adulteration of other drugs in Los Angeles, 2023-2025#222345bioRxiv / medRxiv
• Closed-loop TMS for the Core Clinical Features of the Methamphetamine Use Disorder#883754ClinicalTrials.gov
• Nurses' Experiences Caring for Inpatients Undergoing Psychiatric Care Following Harmful Methamphetamine Use: An Interpretative Phenomenological Study#446891ResearchOnline@ND
• Depression Intervention Among Gay and Bisexual Men Receiving Treatment for Methamphetamine Use#880036ClinicalTrials.gov
• Closed-loop TBS Targeting rPO for the Core Clinical Features of the Methamphetamine Use Disorder#844380ClinicalTrials.gov
• Sex-Differences in the Relationship between Methamphetamine-Use Experience and Spatial Memory in Non-Treatment Seeking Adults#1001883PsyArXiv
• A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence#879435ClinicalTrials.gov
• Administration of an extrasynaptic δ-subunit GABA(A) receptor agonist in the prelimbic cortex attenuates methamphetamine sensitisation and relapse to methamphetamine-seeking behaviour in male rats.#472383NCBI PubMed Central
• Meth circles and pipe pirates: Crystal methamphetamine smoking and identity management among a social network of young adults#646107Open Research
• Sex-Differences in the Relationship between Methamphetamine-Use Experience and Spatial Memory in Non-Treatment Seeking Adults#1001787OSF